“Roflumilast Cream 0.3% Improved the Severity and Impact of Itch in Patients With Chronic Plaque Psoriasis in the Phase 3 DERMIS-1 and DERMIS-2 Studies”, J of Skin, vol. 5, no. 6, p. s41, Nov. 2021, doi: 10.25251/skin.5.supp.41.